SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-072399
Filing Date
2023-06-16
Accepted
2023-06-16 18:46:55
Documents
1
Period of Report
2023-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2319006-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2319006-5_4seq1.xml 4 6010
  Complete submission text file 0001104659-23-072399.txt   7379
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOXCEL THERAPEUTICS, INC. 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address
Rodriguez Javier (Reporting) CIK: 0001847919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 231022788